Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases

Bartels, Tim, De Schepper, Sebastiaan, Hong, Soyon·2020·Science

Cited by (413)

Items 101–200 of 413

  1. Proline Metabolism in Neurological and Psychiatric Disorders
    Yuxiao Yao, Weiping Han · 2022 · Molecules and Cells
  2. Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
    Li, Tianbai, Tan, Xiang, Li, Song, Al-Nusaif, Murad, Le, Weidong · 2021 · Frontiers in Aging Neuroscience
  3. Lipid Homeostasis and Its Links With Protein Misfolding Diseases
    Michele Vendruscolo · 2022 · Frontiers in Molecular Neuroscience
  4. CircLPAR1 Promotes Neuroinflammation and Oxidative Stress in APP/PS1 Mice by Inhibiting SIRT1/Nrf-2/HO-1 Axis Through Destabilizing GDF-15 mRNA
    Wenping Xiong, Dongming Li, Yu Feng, Chenguang Jia, Xiangyu Zhang, Zheng Liu · 2023 · Molecular Neurobiology
  5. Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
    Muhammad Asif Mrza, Jitian He, Youwei Wang · 2024 · International Journal of Molecular Sciences
  6. The Roles of Lpar1 in Central Nervous System Disorders and Diseases
    Dongqiong Xiao, Xiaojuan Su, Hu Gao, Xihong Li, Yi Qu · 2021 · Frontiers in Neuroscience
  7. Reduced inhibition underlies early life LPS exposure induced-cognitive impairment: Prevention by environmental enrichment
    Xin‐miao Wu, Mu‐Huo Ji, Xiaoyu Yin, Hanwen Gu, Tingting Zhu, Run-zhu Wang, Jianjun Yang, Jin-Chun Shen · 2022 · International Immunopharmacology
  8. Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor
    Tianfang Jiang, Chuanying Xu, Shane Gao, Jia Zhang, Jia Zheng, Xiaolin Wu, Qiuyun Lu, Limei Cao, Danjing Yang, Jun Xu et al. · 2022 · npj Parkinson s Disease
  9. Emerging insights between gut microbiome dysbiosis and Parkinson’s disease: Pathogenic and clinical relevance
    Mingxia Bi, Lijuan Feng, Jiahui He, Chang Liu, Yulin Wang, Hong Jiang, Shuang‐Jiang Liu · 2022 · Ageing Research Reviews
  10. Pathological and therapeutic effects of extracellular vesicles in neurological and neurodegenerative diseases
    Paula Izquierdo‐Altarejos, Victoria Moreno‐Manzano, Vicente Felipo · 2023 · Neural Regeneration Research
  11. Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
    Wang, Zhifu, Wang, Qi, Li, Shihua, Li, Xiao-Jiang, Yang, Weili, He, Dajian · 2023 · Frontiers in Aging Neuroscience
  12. Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease
    Zhang, Jing, Wu, Na, Wang, Shubo, Yao, Zitong, Xiao, Fuchuan, Lu, Jing, Chen, Baian · 2021 · Aging Cell
  13. Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease
    Qing Yin Zheng, Hanghang Liu, Yifan Gao, Guozhi Cao, Yusong Wang, Zhen Li · 2024 · Small
  14. Potential targets of microglia in the treatment of neurodegenerative diseases: Mechanism and therapeutic implications
    Wenhui Zhao, Zhongxuan Liu, Jiannan Wu, Anran Liu, Junqiang Yan · 2025 · Neural Regeneration Research
  15. Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease
    Yuying Wang, Honghua Zhang, Dan Liu, Xuelin Li, Lin Long, Ying Peng, Fujian Qi, Yuqing Wang, Weifan Jiang, Zhen Wang · 2022 · Bioorganic Chemistry
  16. Microglia: roles and genetic risk in Parkinson’s disease
    Alex R. Trainor, Debra S. MacDonald, Jay Penney · 2024 · Frontiers in Neuroscience
  17. Microbial pathogens induce neurodegeneration in Alzheimer’s disease mice: protection by microglial regulation
    Tal Ganz, Nina Fainstein, Amit Elad, Marva Lachish, Smadar Goldfarb, Ofira Einstein, Tamir Ben‐Hur · 2022 · Journal of Neuroinflammation
  18. Hawthorn flavonoid ameliorates cognitive deficit in mice with Alzheimer's disease by increasing the levels of Bifidobacteriales in gut microbiota and docosapentaenoic acid in serum metabolites
    Jinxuan Zhang, Junyu Hao, Ran Liu, Tao Wu, Rui Liu, Wenjie Sui, Min Zhang · 2022 · Food & Function
  19. Metabolic stress and age drive inflammation and cognitive decline in mice and humans
    Sarah E. Elzinga, Kai Guo, Ali Turfah, Rosemary E. Henn, Ian F. Webber‐Davis, John M. Hayes, Crystal M. Pacut, Samuel J. Teener, Andrew Carter, Diana M Rigan et al. · 2025 · Alzheimer s & Dementia
  20. A High‐Tryptophan Diet Alleviated Cognitive Impairment and Neuroinflammation in APP/PS1 Mice through Activating Aryl Hydrocarbon Receptor via the Regulation of Gut Microbiota
    Sipei Pan, Yuhe Zhang, Tao Ye, Yu Kong, Xiaorui Cui, Shushu Yuan, Jiaming Liu, Yang Zhang · 2023 · Molecular Nutrition & Food Research
  21. Role of microglia after subarachnoid hemorrhage
    David C. Lauzier, Umeshkumar Athiraman · 2024 · Journal of Cerebral Blood Flow & Metabolism
  22. Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE
    Thanaphong Phongpreecha, Chandresh R. Gajera, Candace C. Liu, Kausalia Vijayaragavan, Alan Lee Chang, Martin Becker, Ramin Fallahzadeh, Rosemary Fernandez, Nadia O. Postupna, Emily Sherfield et al. · 2021 · Science Advances
  23. Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway
    Jing Lv, Jing Zhu, Peihan Wang, Tongyu Liu, Jiang Yuan, Huan Yin, Yiran Lan, Qiang Sun, Zhifeng Zhang, Guoda Ding et al. · 2023 · CNS Neuroscience & Therapeutics
  24. Single-cell and spatial transcriptomics reveals that PTPRG activates the m6A methyltransferase VIRMA to block mitophagy-mediated neuronal death in Alzheimer’s disease
    Donghua Zou, Xiaohua Huang, Yating Lan, Mika Pan, Jieqiong Xie, Qi Huang, Jingyi Zeng, Chun Zou, Zifei Pei, Cuihua Zou et al. · 2024 · Pharmacological Research
  25. Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus
    Nobuya Abe, Masato Tarumi, Yuichiro Fujieda, Nobuhiko Takahashi, Kohei Karino, Mona Uchida, Michihito Kono, Yuki Tanaka, Rie Hasebe, Masaru Kato et al. · 2022 · Annals of the Rheumatic Diseases
  26. Resolvin D1 : A key endogenous inhibitor of neuroinflammation
    Ali Roohbakhsh, Leila Etemad, Gholamreza Karimi · 2022 · BioFactors
  27. Clec7a Worsens Long‐Term Outcomes after Ischemic Stroke by Aggravating Microglia‐Mediated Synapse Elimination
    Hanxi Wan, Mengfan He, Chun Cheng, Kexin Yang, Huanghui Wu, Peilin Cong, Xinwei Huang, Qian Zhang, Yufei Shi, Ji Hu et al. · 2024 · Advanced Science
  28. Making tracks: microglia and the extracellular matrix
    Lauren Katie Wareham, David John Calkins · 2025 · Molecular Neurodegeneration
  29. Ginsenoside compound K acts via LRP1 to alleviate Amyloid β42-induced neuroinflammation in microglia by suppressing NF-κB
    Haishan Jiao, Jianping Jia · 2021 · Biochemical and Biophysical Research Communications
  30. Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease
    Li‐Fan Lin, Yun-Ting Jhao, Chuang‐Hsin Chiu, Lu-Han Sun, Ta-Kai Chou, Chyng‐Yann Shiue, Cheng‐Yi Cheng, Kuo‐Hsing Ma · 2022 · Pharmaceuticals
  31. A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia
    Zuqiang Liu, Hao Dai, Lu Yao, Weifeng Chen, Yun Wang, Liyun Ma, Xiaoqing Li, Shengli Lin, Meng‐Jiang He, Pingting Gao et al. · 2023 · Nature Communications
  32. The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis
    Ying-Juan Liu, Guo-Rui Jia, Sheng-Han Zhang, Yunzi Guo, Xi-Zhen Ma, Hua-Min Xu, Jun-Xia Xie · 2025 · Acta Pharmacologica Sinica
  33. Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer’s disease treatment
    Tian, Limin, Long, Guangyu, Zhu, Siqi, Wang, Yuelong, Xu, Pengcheng, Liu, Lifeng, Yao, Hong, Fang, Shentong, Chen, Shuqing, Li, Suxin · 2025 · Proceedings of the National Academy of Sciences
  34. Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
    Philippe Delbreil, Jean‐Michel Rabanel, Xavier Banquy, Davide Brambilla · 2022 · Advanced Drug Delivery Reviews
  35. 3D models of neurodegeneration: implementation in drug discovery
    Chloe Ann Whitehouse, Nicola J. Corbett, Janet Brownlees · 2023 · Trends in Pharmacological Sciences
  36. Extracellular vesicles from normal tissues orchestrate the homeostasis of macrophages and attenuate inflammatory injury of sepsis
    Xinyu Ge, Qingshu Meng, Xuan Liu, Shanshan Shi, Xuedi Geng, Enhao Wang, Mimi Li, Xiaoxue Ma, Fang Lin, Qianqian Zhang et al. · 2023 · Bioengineering & Translational Medicine
  37. The role of macrophage plasticity in neurodegenerative diseases
    Hongyue Ma, Mingxia Zhu, Mengjie Chen, Xiuli Li, Xinhong Feng · 2024 · Biomarker Research
  38. Intestinal macrophages modulate synucleinopathy along the gut–brain axis
    Sebastiaan De Schepper, Viktoras Konstantellos, James A. Conway, Dimitra Sokolova, Ludovica Zaccagnini, Matthew V. Cowley, Annerieke S. R. Sierksma, M. M. Yudina, Marisa J. Edmonds, Daria Gavriouchkina et al. · 2026 · Nature
  39. Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer’s Disease
    Klaus Grossmann · 2022 · Biomedicines
  40. The link between the gut microbiome, inflammation, and Parkinson’s disease
    Shiqing Nie, Yuan Ge · 2023 · Applied Microbiology and Biotechnology
  41. NLRP3-GSDMD-dependent IL-1β Secretion from Microglia Mediates Learning and Memory Impairment in a Chronic Intermittent Hypoxia-induced Mouse Model
    Chaohong Li, Zhen Zhao, Jiahao Jin, Chenlu Zhao, Baosheng Zhao, Yuzhen Liu · 2023 · Neuroscience
  42. Primary microglia cell cultures in translational research: Strengths and limitations
    István Pesti, Ádám Légrádi, Eszter Farkas · 2024 · Journal of Biotechnology
  43. Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
    Shuyang Xie, Hualong Liu, Ke Yang, Tingting Wang, Hao Zhang, Zhen Li · 2025 · Nano Biomedicine and Engineering
  44. Microglia across evolution: from conserved origins to functional divergence
    Takashi Shimizu, Marco Prinz · 2025 · Cellular and Molecular Immunology
  45. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease
    Xian‐Le Bu, Pu‐Yang Sun, Dong‐Yu Fan, Jun Wang, Hao‐Lun Sun, Yuan Cheng, Gui‐Hua Zeng, Dong‐Wan Chen, Huiyun Li, Xu Yi et al. · 2022 · Science Advances
  46. Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
    Rimpi Arora, Ashish Baldi · 2024 · Current Pharmaceutical Design
  47. Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
    Gunel Ayyubova, Nadeem Fazal · 2024 · Brain Sciences
  48. TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-β-Related Hippocampal Pathophysiology in Mice
    Milan Stoiljković, Karel Otero Gutierrez, Craig Kelley, Tamás L. Horváth, Mihály Hajós · 2021 · Journal of Alzheimer s Disease
  49. Microglial SIRPα Deletion Facilitates Synapse Loss in Preclinical Models of Neurodegeneration
    Chongyun Wu, Luodan Yang, Hannah A. Youngblood, Timon Cheng‐Yi Liu, Rui Duan · 2021 · Neuroscience Bulletin
  50. Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson’s Disease
    Eric A. Bancroft, Rahul Srinivasan · 2022 · Frontiers in Physiology
  51. Cornel Iridoid Glycoside Alleviates Microglia-Mediated Inflammatory Response via the NLRP3/Calpain Pathway
    Cengceng Zheng, Cuicui Yang, Dan Gao, Li Zhang, Yali Li, Lin Li, Lan Zhang · 2022 · Journal of Agricultural and Food Chemistry
  52. Coexistence of Multiple Functional Variants and Genes Underlies Genetic Risk Locus 11p11.2 of Alzheimer’s Disease
    Min Xu, Qianjin Liu, Rui Bi, Yu Li, Hongli Li, Wei-Bo Kang, Zhongjiang Yan, Quanzhen Zheng, Chunli Sun, Maosen Ye et al. · 2023 · Biological Psychiatry
  53. Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease
    Can Cui, Huan Song, Yingying Han, Hongxiang Yu, Hongxia Li, Yumei Yang, Bei Zhang · 2023 · mSphere
  54. Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000–2022
    Lijie Zhang, Qiuru Yao, Jinjing Hu, Baizhi Qiu, Yupeng Xiao, Qi Zhang, Yuting Zeng, Shuqi Zheng, Youao Zhang, Yantong Wan et al. · 2024 · European journal of medical research
  55. Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis
    Yixun Su, Hui Li, Wenjie Zhang, Shi Tao, Qi Wang, Xuan Zhang, Mi Zhou, Xiaomin Huang, Chenmeng Wang, Yong Tang et al. · 2025 · Nature Communications
  56. In Vivo Imaging of the Microglial Landscape After Whole Brain Radiation Therapy
    Brendan S. Whitelaw, Sean Tanny, Carl J. Johnston, Ania Katarzyna Majewska, M. Kerry O’Banion, Brian Marples · 2021 · International Journal of Radiation Oncology*Biology*Physics
  57. Computational Interspecies Translation Between Alzheimer’s Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging
    Meelim J. Lee, Chuangqi Wang, Molly J. Carroll, Douglas K. Brubaker, Bradley T. Hyman, Douglas A. Lauffenburger · 2021 · Frontiers in Neuroscience
  58. Bionic Dormant Body of Timed Wake-Up for Bacteriotherapy in Vivo
    Mingming Guo, Chunrui Yang, Bowen Li, Shixiang Cheng, Qinglu Guo, Dong Ming, Bin Zheng · 2022 · ACS Nano
  59. A novel DPP ‐4 inhibitor Gramcyclin A attenuates cognitive deficits in APP / PS1 /tau triple transgenic mice via enhancing brain GLP ‐1‐dependent glucose uptake
    Zongyang Li, Yuan Zhang, Xiangbao Meng, Min Li, Weiwei Cao, Junshan Yang, Xudong Xu, Wenlan Liu, Weiping Li, Qian Cai et al. · 2022 · Phytotherapy Research
  60. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
    Andrea Amerio, Luca Magnani, Gabriele Arduino, Fabio Fesce, Renato de Filippis, Alberto Parise, Alessandra Costanza, Khoa D. Nguyen, Danièle Saverino, Domenico De Berardis et al. · 2023 · Current Neuropharmacology
  61. Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
    Sahar Balkhi, Anna Di Spirito, Alessandro Delli Poggi, Lorenzo Mortara · 2025 · Cells
  62. Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson’s disease models
    Han Li, Jinghui Wei, Zhigang Zhang, Junyao Li, Yaokai Ma, Ping Zhang, Juntang Lin · 2023 · Stem Cell Research & Therapy
  63. Borneol-Modified Schisandrin B Micelles Cross the Blood–Brain Barrier To Treat Alzheimer’s Disease in Aged Mice
    Feng-rui Li, Yang Yu, Yu-meng Du, Liang Kong, Yang Liu, Jiahua Wang, Mu-han Chen, Mo Liu, Zixu Zhang, Xuetao Li et al. · 2024 · ACS Chemical Neuroscience
  64. Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
    Klaus Grossmann · 2021 · International Journal of Molecular Sciences
  65. S100A9 protein activates microglia and stimulates phagocytosis, resulting in synaptic and neuronal loss
    Katryna Pampuščenko, Silvija Jankevičiūtė, Ramunė Morkūnienė, Darius Šulskis, Vytautas Smirnovas, Guy Charles Brown, Vilmantė Borutaitė · 2025 · Neurobiology of Disease
  66. Inhibiting Immune Crosstalk by Modulation of the Intracellular Function and Extracellular Environment of Diseased Microglia to Boost Parkinson’s Disease Therapy
    Qing Yin Zheng, Yifan Gao, Mengxiao Han, Yusong Wang, Hanghang Liu, Guozhi Cao, Tingting Wang, Hao Zhang, Zhen Li · 2025 · ACS Nano
  67. High spatial-resolution imaging of label-free in vivo protein aggregates by VISTA
    Li‐En Lin, Kun Miao, Chenxi Qian, Lu Wei · 2021 · The Analyst
  68. Targeting the RNA-Binding Protein HuR as Potential Thera-Peutic Approach for Neurological Disorders: Focus on Amyo-Trophic Lateral Sclerosis (ALS), Spinal Muscle Atrophy (SMA) and Multiple Sclerosis
    Vittoria Borgonetti, Elisabetta Coppi, Nicoletta Galeotti · 2021 · International Journal of Molecular Sciences
  69. Synergism of ApoE4 and systemic infectious burden is mediated by the APOE ‐ NLRP3 axis in Alzheimer's disease
    Xueting Liu, Chen Xiu, Na Zhao, Fan Geng, Meng‐Meng Zhu, Qingguo Ren · 2024 · Psychiatry and Clinical Neurosciences
  70. Ganglioside GD3 is up‐regulated in microglia and regulates phagocytosis following global cerebral ischemia
    Jing Wang, Quanguang Zhang, Yujiao Lu, Yan Dong, Krishnan M. Dhandapani, Darrell W. Brann, Robert K. Yu · 2021 · Journal of Neurochemistry
  71. Human α-synuclein aggregation activates ferroptosis leading to parvalbumin interneuron degeneration and motor learning impairment
    Borui Zhang, Kai Chen, Yelin Dai, Xi Luo, Ziwei Xiong, Weijia Zhang, Xiaodan Huang, Kwok‐Fai So, Li Zhang · 2024 · Communications Biology
  72. Severe histomorphological alterations in post‐mortem olfactory glomeruli in Alzheimer’s disease
    Gowoon Son, Harry W.M. Steinbusch, Carmen López‐Iglesias, Cheil Moon, Ali Jahanshahi · 2021 · Brain Pathology
  73. Cytokines and Immune Cells Profile in Different Tissues of Rodents Induced by Environmental Enrichment: Systematic Review
    Matheus Santos de Sousa Fernandes, Gabriela Carvalho Jurema Santos, Tayrine Ordonio Filgueira, Dayane Aparecida Gomes, Elias Almeida Silva Barbosa, Tony Meireles Santos, Niels Olsen Saraiva Câmara, Ângela Castoldi, Fabrício Oliveira Souto · 2022 · International Journal of Molecular Sciences
  74. Anti-inflammatory Therapy Protects Spiral Ganglion Neurons After Aminoglycoside Antibiotic-Induced Hair Cell Loss
    Muhammad Taifur Rahman, Erin M. Bailey, Benjamin M. Gansemer, Andrew A. Pieper, John Robert Manak, Steven H. Green · 2023 · Neurotherapeutics
  75. The STAT1-SLC31A1 axis: Potential regulation of cuproptosis in diabetic retinopathy
    Qiang Hu, Xue Zhang, Jiayang Huang, Hongsong Peng, Yage Sun, Wei Sang, Bo Jiang, Dawei Sun · 2024 · Gene
  76. Regulation of STING G-quadruplex for rescuing cellular senescence and Aβ phagocytic capacity of microglia
    Heying Yuan, Jie Yang, Geng Qin, Yue Sun, Chuanqi Zhao, Chunyu Wang, Jinsong Ren, Xiaogang Qu · 2024 · Chemical Science
  77. Depression exacerbates AD pathology through lactate-dependent activation of microglial Kv1.3 to promote Aβ-containing exosome spreading
    Xiaoli Liu, Huijun Wang, Xi Tian, Yingqi Luo, Minmin Ma, Zilong Zheng, Yaping Wang, Feng Shi, Qiushi Wang, Zhuo Fei Xu et al. · 2025 · Journal of Neuroinflammation
  78. Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease
    Yu‐Chen Yan, Zhiheng Xu, Jian Wang, Wenbo Yu · 2022 · Frontiers in Pharmacology
  79. Astrocytes Excessively Engulf Synapses in a Mouse Model of Alzheimer’s Disease
    Lingjie Li, Shuai Lü, Jie Zhu, Xiaolin Yu, Shengjie Hou, Yaru Huang, Xiaoyun Niu, Xiaoyu Du, Rui‐tian Liu · 2024 · International Journal of Molecular Sciences
  80. Treadmill Exercise Mitigates Alzheimer’s Pathology by Modulating Glial Polarization and Reducing Oligodendrocyte Precursor Cell Perivascular Clustering
    Chongyun Wu, Peibin Zou, Ling Zhu, Shu Feng, Qianting Deng, Timon Cheng‐Yi Liu, Rui Duan, LUODAN YANG · 2025 · Medicine & Science in Sports & Exercise
  81. Abnormal microglial polarization induced by Arid1a deletion leads to neuronal differentiation deficits
    Maolei Gong, Ruoxi Shi, Yijun Liu, Jin-Peng Ke, Xiao Liu, Hong‐Zhen Du, Chang‐Mei Liu · 2022 · Cell Proliferation
  82. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
    Elena Coccia, Tim Ahfeldt · 2021 · Stem Cell Research & Therapy
  83. Functional genome-wide short hairpin RNA library screening identifies key molecules for extracellular vesicle secretion from microglia
    Zhi Ruan, Kayo Takamatsu-Yukawa, Yuzhi Wang, Margaret Ushman, Adam Thomas Labadorf, Maria Ericsson, Seiko Ikezu, Tsuneya Ikezu · 2022 · Cell Reports
  84. Cofilactin rod formation mediates inflammation-induced neurite degeneration
    Gӧkhan Uruk, Ebony Mocanu, Alisa E. Shaw, James R. Bamburg, Raymond A. Swanson · 2024 · Cell Reports
  85. Homotypic targeting of immunomodulatory nanoparticles for enhanced peripheral and central immunity
    Yubo Shen, Daoxia Guo, Xiaoyuan Ji, Yanfeng Zhou, Shuo Liu, Jing Huang, Haiyun Song · 2022 · Cell Proliferation
  86. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease
    Marcello Serra, Annalisa Pinna, Giulia Costa, Alessandro Usiello, Massimo Pasqualetti, Luigi Avallone, Micaela Morelli, Francesco Napolitano · 2021 · International Journal of Molecular Sciences
  87. The Role of Gut Microbiota in Aging and Aging Related Neurodegenerative Disorders: Insights from Drosophila Model
    Yan Kong, Liyuan Wang, Baichun Jiang · 2021 · Life
  88. Traumatic brain injury induced by exposure to blast overpressure via ear canal
    Yi Pang, Hong Zhu, Yang Ou, BradA Clifton, Jinghui Li, David S. Sandlin, Na Li, Li Ming Wu, Chunming Zhang, Tianwen Chen et al. · 2021 · Neural Regeneration Research
  89. Microglia trigger the structural plasticity of GABAergic neurons in the hippocampal CA1 region of a lipopolysaccharide-induced neuroinflammation model
    Juan Chen, Tao Wang, Yuting Zhou, Yiming Hong, Shiyong Zhang, Zhongtao Zhou, Ao Jiang, Danyang Liu · 2023 · Experimental Neurology
  90. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
    Samo Ribarič · 2024 · International Journal of Molecular Sciences
  91. The Role of Osteopontin (OPN) in Regulating Microglia Phagocytosis in Nervous System Diseases
    Pengpeng Li, Zhengxin Tao, Xudong Zhao · 2024 · Journal of Integrative Neuroscience
  92. A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease
    Lijun Dou, Zhenxing Xu, Jielin Xu, Chengxi Zang, Chang Su, Andrew A. Pieper, James B. Leverenz, Fei Wang, Xiongwei Zhu, Jeffrey L. Cummings et al. · 2025 · npj Parkinson s Disease
  93. Advances in the Study of Necroptosis in Vascular Dementia: Focus on Blood–Brain Barrier and Neuroinflammation
    Yuemin Qiu, Lin Cheng, Yinyi Xiong, Ziying Liu, Chunxiao Shen, Liangliang Wang, Yujia Lu, Shufei Wei, Lushun Zhang, Seung‐Bum Yang et al. · 2025 · CNS Neuroscience & Therapeutics
  94. Adaptive immunity in the neuroinflammation of Alzheimer’s disease
    Hanchen Liu, Yun Chen, Jing Zhang, Xiaochun Chen · 2025 · Chinese Medical Journal
  95. Macrophages and Tissue Homeostasis: From Physiological Functions to Disease Onset
    Yehua Li, Huanhuan Chen, Shenao Zhou · 2025 · Frontiers in Bioscience-Landmark
  96. Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
    Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le · 2025 · Translational Neurodegeneration
  97. Improving Blood Monocyte Energy Metabolism Enhances Its Ability to Phagocytose Amyloid-β and Prevents Alzheimer’s Disease-Type Pathology and Cognitive Deficits
    Zhihao Liu, Yu-Di Bai, Zhongyuan Yu, Huiyun Li, Jie Liu, Cheng‐Rong Tan, Gui‐Hua Zeng, Yun‐Feng Tu, Pu‐Yang Sun, Yujuan Jia et al. · 2023 · Neuroscience Bulletin
  98. Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network
    Chuchu Zheng, Wei Dong Zhao, Zeyu Yang, Dier Tang, Muyi Feng, Shuixia Guo · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  99. Memory impairment induced by aluminum nanoparticles is associated with hippocampal IL-1 and IBA-1 upregulation in mice
    Sadegh Izadi, Maryam Abdolrezaei, Roksana SoukhakLari, Maryam Moosavi · 2023 · Neurological Research
  100. Accumulation of extracellular elastin‐derived peptides disturbed neuronal morphology and neuron–microglia crosstalk in aged brain
    Jun Ma, Bingqian Wang, Xiaoxi Wei, Meng Tian, Xingfu Bao, Yifan Zhang, Huichuan Qi, Yi Zhang, Min Hu · 2024 · Journal of Neurochemistry